CZ298799B6 - Použití inhibitoru H+, K+ - ATPázy pro lécbu nazálních polypu - Google Patents

Použití inhibitoru H+, K+ - ATPázy pro lécbu nazálních polypu Download PDF

Info

Publication number: CZ298799B6
Authority: CZ; Czechia
Prior art keywords: treatment; glucocorticoid; atpase inhibitor; alkyl; hydrogen
Prior art date: 1996-10-11

Application number

CZ0122999A

Other languages

Czech (cs)

English (en)

Other versions

CZ122999A3 (cs

Inventor

Lindberg@Per

Pinas-Masso@Joan

Serra-Carreras@Jordi

Trofast@Jan

Original Assignee

Astra Aktiebolag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-10-11

Filing date

1997-10-01

Publication date

2008-02-06

1997-10-01 Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag

1999-09-15 Publication of CZ122999A3 publication Critical patent/CZ122999A3/cs

2008-02-06 Publication of CZ298799B6 publication Critical patent/CZ298799B6/cs

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Otolaryngology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Steroid Compounds (AREA)

CZ0122999A 1996-10-11 1997-10-01 Použití inhibitoru H+, K+ - ATPázy pro lécbu nazálních polypu CZ298799B6 (cs)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SE9603725A SE9603725D0 (sv)	1996-10-11	1996-10-11	New teatment

Publications (2)

Publication Number	Publication Date
CZ122999A3 CZ122999A3 (cs)	1999-09-15
CZ298799B6 true CZ298799B6 (cs)	2008-02-06

Family

ID=20404214

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CZ0122999A CZ298799B6 (cs)	1996-10-11	1997-10-01	Použití inhibitoru H+, K+ - ATPázy pro lécbu nazálních polypu

Country Status (34)

Country	Link
EP (1)	EP0946175B1 (es)
JP (1)	JP4100713B2 (es)
KR (1)	KR100510812B1 (es)
CN (1)	CN1146416C (es)
AR (1)	AR008886A1 (es)
AT (1)	ATE230597T1 (es)
AU (1)	AU738310B2 (es)
BR (1)	BR9711896A (es)
CA (1)	CA2268305C (es)
CZ (1)	CZ298799B6 (es)
DE (1)	DE69718347T2 (es)
DK (1)	DK0946175T3 (es)
EE (1)	EE04043B1 (es)
ES (1)	ES2188995T3 (es)
HK (1)	HK1022848A1 (es)
HU (1)	HUP0000036A3 (es)
ID (1)	ID23692A (es)
IL (1)	IL129324A0 (es)
IS (1)	IS1930B (es)
MY (1)	MY117918A (es)
NO (1)	NO321007B1 (es)
NZ (1)	NZ334786A (es)
PL (1)	PL190902B1 (es)
PT (1)	PT946175E (es)
RS (1)	RS49599B (es)
RU (1)	RU2197966C2 (es)
SA (1)	SA97180641B1 (es)
SE (1)	SE9603725D0 (es)
SK (1)	SK284252B6 (es)
TR (1)	TR199900770T2 (es)
TW (1)	TW568784B (es)
UA (1)	UA59374C2 (es)
WO (1)	WO1998016228A1 (es)
ZA (1)	ZA978842B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6489346B1 (en)	1996-01-04	2002-12-03	The Curators Of The University Of Missouri	Substituted benzimidazole dosage forms and method of using same
US5840737A (en)	1996-01-04	1998-11-24	The Curators Of The University Of Missouri	Omeprazole solution and method for using same
US6846799B1 (en) *	1998-08-18	2005-01-25	The Regents Of The University Of California	Preventing airway mucus production by administration of EGF-R antagonists
US7354894B2 (en)	1998-08-18	2008-04-08	The Regents Of The University Of California	Preventing airway mucus production by administration of EGF-R antagonists
EA004316B1 (ru)	1998-08-18	2004-02-26	Дзе Реджентс Ов Дзе Юниверсити Ов Калифорния	Способ лечения гиперсекреции слизи
EP1180378B8 (en) *	1999-03-03	2011-03-09	Optinose AS	Nasal delivery device
CA2467652A1 (en) *	2001-11-19	2003-05-30	Altana Pharma Ag	Reversible proton pump inhibitors for the treatment of airway disorders
AU2003218726A1 (en) *	2002-03-14	2003-09-22	Altana Pharma Ag	Use of proton pump inhibitors for the treatment of airway disorders
CA2484276A1 (en) *	2002-05-07	2003-11-20	Altana Pharma Ag	Combination of a proton pump inhibitor and a respiratory agent for the treatment of respiratory diseases
MXPA04011018A (es) *	2002-05-07	2005-01-25	Altana Pharma Ag	Nueva combinacion de inhibidores reversibles de la bomba de protones y productos terapueticos para tratar trastornos de las vias respiratorias.
FR2845915B1 (fr) *	2002-10-21	2006-06-23	Negma Gild	Utilisation du tenatoprazole pour le traitement du reflux gastro-oesophagien
PT1572217E (pt)	2002-12-12	2008-11-28	Nycomed Gmbh	Medicamento combinado de r,r-formoterol e ciclesonida
US8993599B2 (en)	2003-07-18	2015-03-31	Santarus, Inc.	Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
AU2004271744B2 (en)	2003-09-16	2010-07-29	Covis Pharma B.V.	Use of ciclesonide for the treatment of respiratory diseases
US8906940B2 (en)	2004-05-25	2014-12-09	Santarus, Inc.	Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
CN104408249B (zh) *	2014-11-24	2017-09-26	广州供电局有限公司	单芯电缆导体热性参数的确定方法及系统
KR101974504B1 (ko) *	2017-04-10	2019-05-03	재단법인 아산사회복지재단	호산구성 비용종 동물모델
JP7614938B2 (ja)	2021-05-11	2025-01-16	日立Astemo株式会社	サスペンション制御装置、およびサスペンション制御方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4199578A (en) *	1977-11-30	1980-04-22	Fisons Limited	Composition
US4364923A (en) *	1972-04-20	1982-12-21	Allen & Hanburs Limited	Chemical compounds

1996
- 1996-10-11 SE SE9603725A patent/SE9603725D0/xx unknown
1997
- 1997-01-10 UA UA99042004A patent/UA59374C2/uk unknown
- 1997-10-01 JP JP51824698A patent/JP4100713B2/ja not_active Expired - Fee Related
- 1997-10-01 CA CA002268305A patent/CA2268305C/en not_active Expired - Fee Related
- 1997-10-01 AT AT97945135T patent/ATE230597T1/de not_active IP Right Cessation
- 1997-10-01 RU RU99109596/14A patent/RU2197966C2/ru not_active IP Right Cessation
- 1997-10-01 WO PCT/SE1997/001651 patent/WO1998016228A1/en active IP Right Grant
- 1997-10-01 DE DE69718347T patent/DE69718347T2/de not_active Expired - Fee Related
- 1997-10-01 IL IL12932497A patent/IL129324A0/xx not_active IP Right Cessation
- 1997-10-01 SK SK384-99A patent/SK284252B6/sk unknown
- 1997-10-01 BR BR9711896A patent/BR9711896A/pt not_active Application Discontinuation
- 1997-10-01 EE EEP199900118A patent/EE04043B1/xx not_active IP Right Cessation
- 1997-10-01 DK DK97945135T patent/DK0946175T3/da active
- 1997-10-01 PL PL332692A patent/PL190902B1/pl not_active IP Right Cessation
- 1997-10-01 RS YUP-163/99A patent/RS49599B/sr unknown
- 1997-10-01 PT PT97945135T patent/PT946175E/pt unknown
- 1997-10-01 ID IDW990139D patent/ID23692A/id unknown
- 1997-10-01 CZ CZ0122999A patent/CZ298799B6/cs not_active IP Right Cessation
- 1997-10-01 KR KR10-1999-7003115A patent/KR100510812B1/ko not_active IP Right Cessation
- 1997-10-01 ES ES97945135T patent/ES2188995T3/es not_active Expired - Lifetime
- 1997-10-01 HU HU0000036A patent/HUP0000036A3/hu unknown
- 1997-10-01 CN CNB971985847A patent/CN1146416C/zh not_active Expired - Fee Related
- 1997-10-01 EP EP97945135A patent/EP0946175B1/en not_active Expired - Lifetime
- 1997-10-01 AU AU46409/97A patent/AU738310B2/en not_active Ceased
- 1997-10-01 NZ NZ334786A patent/NZ334786A/xx unknown
- 1997-10-01 TR TR1999/00770T patent/TR199900770T2/xx unknown
- 1997-10-02 ZA ZA9708842A patent/ZA978842B/xx unknown
- 1997-10-07 TW TW086114622A patent/TW568784B/zh not_active IP Right Cessation
- 1997-10-07 MY MYPI97004697A patent/MY117918A/en unknown
- 1997-10-08 AR ARP970104655A patent/AR008886A1/es unknown
- 1997-11-23 SA SA97180641A patent/SA97180641B1/ar unknown
1999
- 1999-04-06 NO NO19991619A patent/NO321007B1/no unknown
- 1999-04-08 IS IS5021A patent/IS1930B/is unknown
2000
- 2000-04-03 HK HK00102015A patent/HK1022848A1/xx not_active IP Right Cessation

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4364923A (en) *	1972-04-20	1982-12-21	Allen & Hanburs Limited	Chemical compounds
US4199578A (en) *	1977-11-30	1980-04-22	Fisons Limited	Composition

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
(David Johnson), World literature rewiev str. 2245 (sloupec 2) -2246, -American J. of Gastroenterology *
(M.M YOUSFI) et al., Resolution of. M.D.Polyp.A.C.of H.p. Infection, str. 53-54, J CLIN GASTROENTEROL *

Also Published As

Publication number	Publication date
HK1022848A1 (en)	2000-08-25
ES2188995T3 (es)	2003-07-01
TR199900770T2 (xx)	1999-06-21
YU16399A (sh)	2000-03-21
CN1232397A (zh)	1999-10-20
CA2268305A1 (en)	1998-04-23
SE9603725D0 (sv)	1996-10-11
HUP0000036A3 (en)	2003-02-28
RU2197966C2 (ru)	2003-02-10
NO321007B1 (no)	2006-02-27
NO991619D0 (no)	1999-04-06
DE69718347T2 (de)	2003-08-28
DE69718347D1 (de)	2003-02-13
RS49599B (sr)	2007-06-04
CZ122999A3 (cs)	1999-09-15
JP4100713B2 (ja)	2008-06-11
HU0000036D0 (es)	2002-05-29
IS1930B (is)	2004-05-18
AU4640997A (en)	1998-05-11
BR9711896A (pt)	1999-08-24
SA97180641B1 (ar)	2005-12-18
UA59374C2 (uk)	2003-09-15
ATE230597T1 (de)	2003-01-15
KR100510812B1 (ko)	2005-08-31
SK284252B6 (sk)	2004-12-01
SK38499A3 (en)	2000-03-13
WO1998016228A1 (en)	1998-04-23
PL332692A1 (en)	1999-09-27
EP0946175A1 (en)	1999-10-06
PT946175E (pt)	2003-04-30
IS5021A (is)	1999-04-08
NO991619L (no)	1999-04-06
AR008886A1 (es)	2000-02-23
JP2001508034A (ja)	2001-06-19
NZ334786A (en)	2000-12-22
CN1146416C (zh)	2004-04-21
HUP0000036A2 (hu)	2002-05-29
EP0946175B1 (en)	2003-01-08
EE9900118A (et)	1999-10-15
TW568784B (en)	2004-01-01
KR20000049046A (ko)	2000-07-25
IL129324A0 (en)	2000-02-17
PL190902B1 (pl)	2006-02-28
ID23692A (id)	2000-05-11
ZA978842B (en)	1998-04-14
DK0946175T3 (da)	2003-03-17
MY117918A (en)	2004-08-30
EE04043B1 (et)	2003-06-16
CA2268305C (en)	2006-11-28
AU738310B2 (en)	2001-09-13

Publication	Publication Date	Title
CZ298799B6 (cs)	2008-02-06	Použití inhibitoru H+, K+ - ATPázy pro lécbu nazálních polypu
US6599927B2 (en)	2003-07-29	Use of an H+, K+-ATPase inhibitor in the treatment of Widal's Syndrome
RU2292208C2 (ru)	2007-01-27	Новая комбинация не оказывающих седативного действия противогистаминных средств с соединениями, влияющими на действие лейкотриена, для лечения ринита/конъюнктивита
ATE477804T1 (de)	2010-09-15	Verfahren zur behandlung von entzündlichen erkrankungen des verdauungstrakts mit topisch wirksamen kortikosteroiden
JP6501774B2 (ja)	2019-04-17	Ｍａｂａ化合物およびコルチコステロイドを含む組合せ剤
JP2011021043A (ja)	2011-02-03	アレルギー性鼻炎を治療するためのシクレソニドと抗ヒスタミン剤との組合せ物の使用
AU2003255365B2 (en)	2009-02-19	Novel combination of glucocorticoids and PDE-4-inhibitors for treating respiratory diseases, allergic diseases, asthma and COPD
JP2008110991A (ja)	2008-05-15	処置方法
US9636350B2 (en)	2017-05-02	Pharmaceutical composition for use in nasal administration containing corticoid, and a quinolone or fusidic acid
CN1897952B (zh)	2010-12-08	中性白细胞增多抑制剂
CN115581697A (zh)	2023-01-10	尼古丁及衍生物作为FXR-meglin/cublin调节剂在制备利胆产品中的应用
JPWO2020245382A5 (es)	2023-06-09
Sandborn	1998	Nicotine in the treatment of ulcerative colitis
ZA200501582B (en)	2005-09-09	Treatment of non-allergic rhinitis by means of selective phosphodiesterase-4-inhibitors.

Legal Events

Date	Code	Title	Description
2000-06-30	PD00	Pending as of 2000-06-30 in czech republic
2009-01-28	MM4A	Patent lapsed due to non-payment of fee	Effective date: 19971001